Bilthoven Biologicals
Bilthoven, Netherlands bbio.nl From their website, Nov 2026
- GMP
Work here? Claim this listing
About
Bilthoven Biologicals develops, manufactures, tests, releases, registers, and distributes vaccines and viral vector products. It serves public health partners and vaccine programs from Bilthoven, the Netherlands, with distribution to more than 140 countries.
Services
Drug substance production
Production of viral vaccines and viral vectors from infected cells to purified bulk, including cell growth, virus infection, inactivation, harvest, purification, and sterile filtration.
Drug product
Formulation and aseptic filling of vaccines into vials and prefilled syringes, including inspection, labelling, and serialisation-ready lines.
Seed lots and cell banks
Production, banking, characterisation, release, and qualified storage of master and working cell banks and virus seeds.
Market entry
Quality control testing, QP certification, batch release, import, GMO handling, warehousing, and distribution services for products entering the EU.
Capabilities
- Assays and studies
- HEK293
- Bioreactors
- Quality control testing
- Microbiology
- Stability testing
- Characterisation
- Release panel
- Scale and capacity
- Bioreactor scale from 20 litres through 200 to 2,000 litres
- Filling of 2R and 6R vials, with 10R and 20R as options: up to 70,000 vials a day
- Filling of 1.1 mL prefilled syringes: up to 33,000 a day
- Formulation in single-use systems, from 50 to 200 litres
- Qualified storage from −180 °C to +20 °C
- At least 300 million vaccines per year
- Therapeutic areas
- Infectious diseases
- Public health
Modalities and species
- Modalities
- Viral vector
- Vaccine
- Species and models
- Vero cells
- HEK293 cells
Industries served
- Public health
- Vaccines
Details
- Type
- CMO
- Founded
- 1909
- Address
- Leeuwenhoeklaan 9 3721 MA Bilthoven Netherlands
- Serves
- Global, Europe, more than 140 countries, 90+ countries served
- Phone
- +31 (0)30 800 4800